EG-COVID

· EyeGene Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EG-COVID, covering 2025-03-07 to 2025-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers [Phase 1, Phase 2]

See pricing